Clinical and Molecular Hepatology

"Lynna Alnimer"

Editorial

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future: Lynna Alnimer, Mazen Noureddin; Clin Mol Hepatol 2023;29(2):394-397.
Published online April 1, 2023; DOI: https://doi.org/10.3350/cmh.2023.0104

Citations

Citations to this article as recorded by

MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways
Shengfang Liu, Qingjuan Zhang, Lijing Wang, Qin Tang, Bingtao Hu
Frontiers in Medicine.2026;[Epub] CrossRef
Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond
Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas
Liver Research.2026;[Epub] CrossRef
Collagen fibers quantification for liver fibrosis assessment using linear dichroism photoacoustic microscopy
Yang Qiu, Honghui Li, Kun Yu, Jiali Chen, Li Qi, Yinghua Zhao, Liming Nie
Photoacoustics.2025; 42: 100694. CrossRef